Redeye provides a review following AcouSort's Q2 2026 report, which, apart from slight deviations from our forecasts, came in largely in line with expectations and showed no major surprises. We have made some minor adjustments to our estimates and updated our capital raising assumptions, though neither has a material effect on our fundamental valuation (base case). Furthermore, we introduce our new fair value, with the share screening as "cheap" at current levels.
LÄS MER
